News & Events

5 Steps to Nurture Up-and-Coming Leaders in Health Care

Key opinion leaders (KOLs) are an essential group of people for the pharma industry. Considering all the rules and regulations that surround health care, especially in marketing practices, an effective thought leader must be both an advocate and an expert.

These leaders are adept at navigating internal and external communications, and they can often amplify your message more effectively than any other traditional marketing mediums. Moreover, thought leaders are valuable because they contribute to clinical activities such as drug development or identifying new indications for an existing compound.

Health care has an ever-changing landscape: costs rise, approval processes get more complex, and an aging population requires new approaches to care. On top of all that, the industry needs to recognize and integrate new opportunities that involve technology—both in clinical settings and in marketing practices—and new channels to push awareness. To do this effectively, pharma needs to engage KOLs in both strategy development activities and in advocacy-building exercises.

Besides technological proficiency, thought leaders should be true visionaries at the forefront of their organizations and demonstrate notable drive and resourcefulness. For pharma companies to experience success with certain campaigns, they should recognize KOLs early on and sustain critical engagement throughout the development process. In order for a company to identify rising stars in the pharma industry, they should partner with a boutique communications agency whose services offer leadership programs.

1. Identify leadership qualities

Typically, a pharma company enlists an in-house team to manage and engage with industry KOLs. This branch of management is adept at identifying leadership by monitoring and encouraging an individual’s professional capabilities. Of course, a number of analytical tools can evaluate certain qualities that make for an effective leader. While the task of identifying thought leaders can be daunting, a medical communications agency understands the best approach to recruiting and partnering with a diverse array of leaders.

Keep in mind that the qualities you seek in a new crop of KOLs might not intersect with traditional qualifications assigned to thought leaders. Look for potential leaders who can lend credible voices to both social and professional communications, who use creative approaches to industry practices, who are innovative at heart, and to whom collaboration is a valuable exercise.

2. Provide mentorship to up-and-coming leaders

When you identify promising leaders, your company can proactively cultivate their leadership skills by involving future KOLs in training programs and establishing meaningful trajectories for their careers. For those with authentic leadership qualities, knowledge and experience are compelling incentives; a mentorship program is one of the best ways to support and acknowledge rising stars.

Pairing up-and-coming leaders with appropriate mentors in the field can be a powerful yet disciplined experience that prepares them for actual leadership opportunities. Providing these prospective KOLs with access to resources and specific knowledge that supports their own ideas and projects is invaluable, and mentors can further offer feedback and encouragement, or even engage in potential collaborations.

3. Challenge prospective leaders with opportunities

An up-and-coming leader should not only rise to challenges, but welcome them. Testing a prospective KOL is a smart approach that can predict their success in a real leadership position. It’s important to present these individuals with opportunities that test their creativity and resourcefulness, require setting appropriate goals and developing strategies to achieve them, and necessitate collaboration with different departments within the organization.

This new crop of leaders craves engagement on a highly interactive level. Eliciting their participation in activities that range from clinical practices to marketing strategies is imperative and also tests their leadership abilities in different settings. Furthermore, providing these individuals with appropriate challenges is a good way to gauge the authenticity of relationships they build in the process—a key for successful leadership.

4. Allow your mentees to lead real-world projects

Besides challenging rising stars to see whether they have the right stuff when it comes to various industry practices, allow them to drive the marketing conversation or manage specific pharma-related activities. It’s important to see what these up-and-coming KOLs can do by giving them exclusive access to develop new products or services. The next step in designating their KOL status relies on your trust and confidence in their abilities. But to earn this trust, they must include consistency, reliability, and credibility in their approach to leadership. There is no better way to assess these qualities than to exercise them through actual real-world scenarios.

5. Recognize and acknowledge accomplishments

Who doesn’t want to feel appreciated? Recognition of accomplishments is vital in cultivating a strong, dedicated KOL. This doesn’t just mean monetary rewards; dig in to find what means most to the individual. For example, appoint prospective KOLs as members on a board important to their own research and interests. Nominate them to regional or national programs that recognize good leadership skills or endorse their participation in recent medical conferences. Remember, these rising stars are the future of pharma, and the cultivation of their leadership abilities is vital to the industry.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.
Aptitude Health
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.